Expanded Access to ABBV-400 - Trial NCT05982873
Access comprehensive clinical trial information for NCT05982873 through Pure Global AI's free database. This phase not specified trial is sponsored by AbbVie and is currently Available. The study focuses on Non-Small Cell Lung Cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
AbbVie
Timeline & Enrollment
N/A
N/A
N/A
Summary
This is an expanded access program (EAP) for eligible participants. This program is designed
 to provide access to ABBV-400 prior to approval by the local regulatory agency. Availability
 will depend on territory eligibility. A medical doctor must decide whether the potential
 benefit outweighs the risk of receiving an investigational therapy based on the individual
 patient's medical history and program eligibility criteria.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05982873
Non-Device Trial